Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV

被引:6
|
作者
Wilder-Smith, A. [1 ,2 ]
机构
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
关键词
CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine;
D O I
10.1016/j.cmi.2018.03.024
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:680 / 681
页数:2
相关论文
共 50 条
  • [1] SAFETY OF DENGUE VACCINE (CYD-TDV) IN ASIA: A SYSTEMATIC REVIEW
    Ismail, W. R. Wan
    Majid, M. Sh Abdul
    Li, H. Y.
    Madrim, M. F.
    Rahim, S. Sh S. Abdul
    Jeffree, M. S.
    Azhar, Z., I
    Ghazi, H. F.
    Hassan, M. R.
    INFEKTSIYA I IMMUNITET, 2021, 11 (03): : 447 - 453
  • [2] INTEGRATED IMMUNOGENICITY ANALYSIS OF A TETRAVALENT DENGUE VACCINE (CYD-TDV) UP TO 4 YEARS AFTER VACCINATION
    Vigne, Claire
    Dupuy, Martin
    Richetin-Guilluy, Aline
    Guy, Bruno
    Jackson, Nicholas
    Bonaparte, Matthew
    Hu, Branda
    Saville, Melanie
    Chansinghakul, Danaya
    Noriega, Fernando
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 434 - 434
  • [3] Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
    Forrat, Remi
    Dayan, Gustavo H.
    DiazGranados, Carlos A.
    Bonaparte, Matthew
    Laot, Thelma
    Rosario Capeding, Maria
    Sanchez, Leilani
    Leticia Coronel, Diana
    Reynales, Humberto
    Chansinghakul, Danaya
    Hadinegoro, Sri Rezeki S.
    Perroud, Ana Paula
    Frago, Carina
    Zambrano, Betzana
    Machabert, Tifany
    Wu, Yukun
    Luedtke, Alexander
    Price, Brenda
    Vigne, Claire
    Haney, Owen
    Savarino, Stephen J.
    Bouckenooghe, Alain
    Noriega, Fernando
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : 1003 - 1012
  • [4] Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
    Ngoc Huu Tran
    Chansinghakul, Danaya
    Chong, Chia Yin
    Low, Chian Yong
    Shek, Lynette P.
    Chan Quang Luong
    Fargo, Carina
    Wartel, T. Anh
    Sun, Sunny
    Skipetrova, Anna
    Bouckenooghe, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2315 - 2327
  • [5] 3 years of post-licensure safety data on a live attenuated tetravalent dengue vaccine (CYD-TDV)
    Rojas, Andrey
    Haney, Owen
    Marcelon, Lydie
    Khromava, Alena
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 390 - 391
  • [6] Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America
    Arredondo-Garcia, J. L.
    Hadinegoro, S. R.
    Reynales, H.
    Chua, M. N.
    Medina, D. M. Rivera
    Chotpitayasunondh, T.
    Tran, N. H.
    Deseda, C. C.
    Wirawan, D. N.
    Cortes Supelano, M.
    Frago, C.
    Langevin, E.
    Coronel, D.
    Laot, T.
    Perroud, A. P.
    Sanchez, L.
    Bonaparte, M.
    Limkittikul, K.
    Chansinghakul, D.
    Gailhardou, S.
    Noriega, F.
    Wartel, T. A.
    Bouckenooghe, A.
    Zambrano, B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (07) : 755 - 763
  • [7] IMMUNOGENICITY OF THE CYD TETRAVALENT DENGUE VACCINE (CYD-TDV) USING A COMPRESSED SCHEDULE: RANDOMIZED PHASE II STUDY IN US ADULTS
    Kirstein, Judith
    Douglas, William
    Thakur, Manoj
    Boaz, Mark
    Papa, Thomas
    Skipetrova, Anna
    Plennevaux, Eric
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 433 - 433
  • [8] VIRAL GENETIC DIVERSITY AND PROTECTIVE EFFICACY OF A CYD-TDV TETRAVALENT DENGUE VACCINE IN A PHASE 3 TRIAL IN ASIA
    Magaret, Craig A.
    Juraska, Michal
    Shao, Jason
    Carpp, Lindsay N.
    Fiore-Gartland, Andrew J.
    Benkeser, David
    Girerd-Chambaz, Yves
    Langevin, Edith
    Frago, Carina
    Guy, Bruno
    Edlefsen, Paul T.
    Gilbert, Peter B.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05): : 194 - 194
  • [9] Clinical efficacy, Safety, and immunogenicity of a Live Attenuated Tetravalent Dengue vaccine (CYD-TDv) in Children: A Systematic Review with Meta-analysis
    Malisheni, Moffat
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Takah, Noah
    Murewanhema, Grant
    Bates, Matthew
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [10] CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety
    Godoi, Isabella Piassi
    Pires Lemos, Livia Lovato
    de Araujo, Vania Eloisa
    Bonoto, Braulio Cesar
    Godman, Brian
    Guerra Junior, Augusto Afonso
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 165 - 180